Sunday, February 8, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Reiterates Buy Rating and Sets Price Target for Plexus

Elaine Mendonca by Elaine Mendonca
March 8, 2024
in Breaking News
0
SNDR stock news
0
SHARES
4
VIEWS
Share on FacebookShare on Twitter

On March 8, 2024, analyst David Williams from Benchmark reiterated a Buy rating on Plexus (NASDAQ: PLXS) and set a price target of $110. This reaffirmation reflects Benchmark’s optimistic view on Plexus, showing strong confidence in the company’s future performance and growth prospects.

Plexus Corp (PLXS) Stock Sees Slight Increase on March 8, 2024: Is This the Start of a New Trend?

On March 8, 2024, Plexus Corp (PLXS) experienced a slight increase in its stock performance. The stock opened at $96.55, which was $1.09 higher than its previous close. Throughout the trading day, the price of PLXS shares continued to rise, ending the day with a $0.28 increase, a 0.29% rise from the previous close. Investors may be keeping a close eye on PLXS to see if this upward momentum can be sustained in the coming days. It will be important to monitor any further price movements to determine if this is a temporary blip or the start of a more significant trend.

Plexus Corp (PLXS) Stock Performance Fluctuates on Latest Financial Data

On March 8, 2024, Plexus Corp (PLXS) saw some fluctuations in its stock performance based on the latest financial data provided by CNN Money. The total revenue for Plexus Corp in the past year was reported at $4.21 billion, showing a 10.47% increase compared to the previous year. However, in the first quarter of the current fiscal year, the total revenue dropped to $982.61 million, marking a 4.04% decrease from the previous quarter. Similarly, the net income for Plexus Corp was $139.09 million in the past year, remaining flat compared to the previous year. However, in the first quarter of the current fiscal year, the net income decreased to $29.21 million, representing a significant 27.44% decline from the previous quarter. Furthermore, the earnings per share (EPS) for Plexus Corp was reported at $4.95 in the past year, showing no change compared to the previous year. However, in the first quarter of the current fiscal year, the EPS dropped to $1.04, marking a substantial 27.54% decrease from the previous quarter. Overall, the fluctuations in Plexus Corp’s financial performance, particularly the decrease in revenue, net income, and EPS in the first quarter of the current fiscal year, may have impacted its stock performance on March 8, 2024. Investors and analysts will likely closely monitor the company’s future financial reports to assess its growth prospects and potential for stock price recovery.

Tags: PLXS
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance_Budgeting (1)

Analyst Reaffirms Buy Rating for Bristow Group with 40 Price Target

Technology Blockchain Stock Market Today

Analyst Bullish on Akamai Technologies Raises Price Target to 140

Finance_Commercial (2)

Whales Show Positive Outlook on Walmart Stock Options

Recommended

Century Aluminum Stock

Century Aluminum Gains Momentum from Tariff Policy and Expansion Plans

5 months ago
KAR Auction Services Stock

Digital Auto Marketplace OPENLANE Surges on Exceptional Quarterly Performance

6 months ago
Procter & Gamble Stock

Procter & Gamble Shares: A Tale of Conflicting Signals

5 months ago
Roblox Registered (A) Stock

Platform Power vs. Engine Excellence: A Tale of Two Tech Titans

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Cassava Sciences Confirms Alzheimer Drug Failure and Faces Regulatory Delays

DroneShield Shares Face Headwinds Despite Record Performance

Rock Tech Lithium: Investors Await the Final Go-Ahead

Puma Biotechnology Sets Date for Full-Year Financial Disclosure

Quanterix Seeks FDA Clearance for Groundbreaking Alzheimer’s Blood Test

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

Trending

SuRo Capital Stock
AI & Quantum Computing

SuRo Capital Sharpens Focus on AI Infrastructure Investments

by Jackson Burston
February 8, 2026
0

Investment firm SuRo Capital is strategically increasing its exposure to the artificial intelligence sector, aiming to capitalize...

Chicago Atlantic Real Estate Finance Stock

Tax Clarity and Sector Optimism Bolster Outlook for Chicago Atlantic

February 8, 2026
RBB Stock

RBB Bancorp Reports Strong Asset Quality Improvement and Strategic Capital Review

February 8, 2026
Cassava Sciences Stock

Cassava Sciences Confirms Alzheimer Drug Failure and Faces Regulatory Delays

February 8, 2026
DroneShield Stock

DroneShield Shares Face Headwinds Despite Record Performance

February 8, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • SuRo Capital Sharpens Focus on AI Infrastructure Investments
  • Tax Clarity and Sector Optimism Bolster Outlook for Chicago Atlantic
  • RBB Bancorp Reports Strong Asset Quality Improvement and Strategic Capital Review

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com